GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi Ticaret Share News
0.000.00%
Last trade - 00:00- TRY18.09bn
- TRY23.17bn
- TRY19.18bn
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira
Brief: Gen Ilac Says No Funds Hold Genil Shares Exceeding 3% Of Share Capital As Of Current Date
Brief: Gen Ilac Says It Buys 41.79% Of Neo Auvra Share Capital
Brief: GEN Ilac Q2 Net Profit Up At 490.3 Mln Lira YoY
Brief: GEN Ilac Says Affiliate Company's Tender Win To Contribute 641.5 Mln Lira To Sales
Turkey's pharma company Gen Ilac jumps after Q1 results
Brief: GEN Ilac Q1 Net Profit Shrinks To 375.1 Mln Lira YoY
Brief: Gen Ilac Says It Terminates Share Buy-Back Program, Bought-Back Shares Represent 0.1033% Of Capital
Brief: Gen Ilac Says It Receives First Regulatory Pharmaceutical Approval In Latin America From Mexican Health Authority
Brief: Gen Ilac - Signs 5-Year Exclusive Distribution Agreement With Pfizer Effective May 1, 2026
Brief: Gen Ilac Says It Completes Construction Of 2.3 MW Solar Power Plant In Babaeski, Kirklareli
Brief: Gen Ilac Says Pharmaceutical Production Facility In Azerbaijan Targeted To Be Commissioned In October 2026
Brief: Gen Ilac Says It Receives Ethical Board Approval In The Netherlands For Phase 2 Trial Of Drug Candidate Sul-238
Brief: Gen Ilac Says Proposes To Pay Cash Dividend At Gross 0.05 Lira Per Share For 2025
Brief: Gen Ilac FY Net Profit Up At 814.4 Mln Lira YoY
Brief: Gen Ilac Says Unit Salutem's State Supply Office Tender Win To Add 652.7 Mln Lira Worth Of Sales For Company